SLC36A2
(Solute Carrier Family 36 (Proton/amino Acid Symporter), Member 2 (SLC36A2))
Protein Region
N-Term
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-SLC36A2 antibody (Catalog #: ARP44156_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
SLC36A2
Reaktivität: Human
Wirt: Synthetic
BP, BI
Sodium azide
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
SLC36A2
(Solute Carrier Family 36 (Proton/amino Acid Symporter), Member 2 (SLC36A2))
Synonyme
DKFZp469P1320 Peptide, PAT2 Peptide, TRAMD1 Peptide, A530067G19Rik Peptide, Tramd1 Peptide, Pat2 Peptide, solute carrier family 36 member 2 Peptide, solute carrier family 36 (proton/amino acid symporter), member 2 Peptide, SLC36A2 Peptide, Slc36a2 Peptide
Hintergrund
SLC36A2 is involved in a pH -dependent electrogenic neuronal transport and sequestration of small amino acids amino acids such as glycine, alanine and proline. SLC36A2 is inhibited by sarcosine.
Alias Symbols: FLJ16051, MGC119658, MGC119660, PAT2, TRAMD1